What are the contraindications for Azithromycin (macrolide antibiotic)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Azithromycin Contraindications

Azithromycin is contraindicated in patients with hypersensitivity to azithromycin, erythromycin, any macrolide, or any ketolide antibiotics, and in those with a history of cholestatic jaundice or hepatic dysfunction associated with previous use of azithromycin. 1

Primary Contraindications

  • Hypersensitivity reactions:

    • Previous allergic reactions to azithromycin or any macrolide/ketolide antibiotic
    • History of Stevens-Johnson syndrome, toxic epidermal necrolysis, or other severe cutaneous adverse reactions with macrolides 2
  • Hepatic conditions:

    • History of cholestatic jaundice/hepatic dysfunction with previous azithromycin use
    • Active liver disease requiring monitoring if azithromycin must be used 1, 2
  • Cardiac conditions requiring caution or avoidance:

    • Known QT interval prolongation
    • History of torsades de pointes
    • Congenital long QT syndrome
    • Uncompensated heart failure
    • Bradyarrhythmias 2

Drug Interactions Requiring Avoidance

Azithromycin should not be used concurrently with:

  • QT-prolonging medications:

    • Class IA antiarrhythmics (quinidine, procainamide)
    • Class III antiarrhythmics (dofetilide, amiodarone, sotalol)
    • Certain antiemetics (domperidone)
    • Antipsychotics with known QT effects 1, 2
  • Medications with serious interaction potential:

    • Ergot derivatives (risk of ergotism)
    • Patients taking medications with narrow therapeutic windows that interact with azithromycin 1

Special Populations Requiring Caution

  • Non-tuberculous mycobacterial (NTM) infections:

    • Current NTM infection is a contraindication to low-dose macrolide monotherapy
    • Patients should be screened for NTM before starting long-term azithromycin therapy 1
  • Myasthenia gravis:

    • Use with extreme caution as azithromycin may exacerbate symptoms 1, 3
  • Electrolyte abnormalities:

    • Uncorrected hypokalemia or hypomagnesemia increases risk of QT prolongation 2
  • Elderly patients:

    • Higher susceptibility to QT interval prolongation effects 2

Monitoring Requirements When Use Is Necessary

If azithromycin must be used in patients with risk factors:

  1. Cardiac monitoring:

    • Baseline ECG and follow-up monitoring in patients with cardiac risk factors
    • Discontinue immediately if QTc >500ms or if ventricular arrhythmias develop 1
  2. Hepatic monitoring:

    • Baseline and periodic liver function tests
    • Discontinue immediately if signs of hepatitis occur 2
  3. Electrolyte monitoring:

    • Check potassium and magnesium levels before initiating therapy in at-risk patients 2

Important Considerations for Clinical Practice

  • The risk of QT prolongation and potentially fatal torsades de pointes should be carefully weighed against benefits, particularly in elderly patients and those with cardiac risk factors 2

  • Patients on long-term azithromycin therapy should be monitored for development of resistant organisms, particularly in respiratory conditions 1

  • When treating infections in patients with contraindications to azithromycin, alternative antibiotic classes should be considered based on the specific pathogen and infection site

  • For patients with a history of macrolide allergy, cross-reactivity between different macrolides should be considered, with azithromycin potentially being more allergenic than clarithromycin in children 4

By carefully screening for these contraindications before prescribing azithromycin, clinicians can significantly reduce the risk of serious adverse events and improve patient safety.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Antibiotic Use in Myasthenia Gravis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.